Scientists Say House Cats Could Help Unlock New Cancer Treatments for Humans

The Breakthrough

Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human cancers. The landmark study, published in the journal Science, represents a major shift in how researchers approach cancer drug development by leveraging a previously overlooked resource: domestic cats.

Scientists have cracked open the "black box" of feline cancer in a landmark study that genetically analyzed nearly 500 cat tumors from around the world. The team sequenced and analyzed tumor samples from cats suffering from a diverse range of cancer types, creating what researchers call "the oncogenome of the domestic cat." Scientists also identified similarities between feline and human cancers affecting the blood, bones, lungs, skin, gastrointestinal tract, and central nervous system.

Why Cats Matter

Cats develop cancer spontaneously and naturally, similar to humans, making them more relevant models than laboratory animals that are genetically engineered to develop tumors. Key mutations—like those linked to breast cancer—appear in both feline and human malignancies. This natural convergence suggests that understanding what causes cancer in cats can directly inform human cancer research.

The overlap is particularly significant for common tumor types. Rather than relying solely on mouse models or cell culture studies, this research demonstrates that naturally occurring feline cancers can provide insights into tumor development, progression, and potential therapeutic targets. The breadth of the analysis—examining nearly 500 tumors—provides researchers with a robust dataset to identify patterns and genetic drivers.

Future Applications

The findings position domestic cats as biological "intermediaries" between laboratory models and humans. Cancer researchers can now examine which genetic mutations appear consistently across feline tumors and explore how those same mutations contribute to human disease. This approach could accelerate the identification of new drug targets and therapeutic strategies.

With millions of cats living in homes worldwide and naturally developing cancers at rates comparable to humans, this reservoir of biological data represents an untapped resource for cancer research. Veterinary records, tumor banks, and collaborative networks between research institutions and veterinary practices could yield additional insights.

Path Forward

The research opens new collaboration opportunities between veterinary oncologists and human cancer researchers. Understanding how feline cancers respond to existing treatments, as well as identifying new vulnerabilities in cat tumors, could guide the development of next-generation cancer therapies that may ultimately benefit both cats and humans. This cross-species approach highlights how translational research often benefits from unexpected partnerships and perspectives.